Evaluation of serum ESPL1 as a biomarker for early diagnosis of HBV-related hepatocellular carcinoma
ESPL1 is a potential biomarker for tracking chronic HBV infection and predicting the development of HBV-HCC. Monitoring ESPL1 levels in serum could help with early detection and personalized screening HBV-HCC for individuals with chronic HBV infection.
Authors
- Haiping Liang (ORCID: https://orcid.org/0009-0000-6225-3394)
- Jianning Jiang (ORCID: https://orcid.org/0009-0005-1354-5127)
- Hengkai Liang
- Lu-Huai Feng (ORCID: https://orcid.org/0000-0002-1715-4028)
- Bobin Hu (ORCID: https://orcid.org/0009-0008-4710-775X)
- Lu Wei
- Long Huang (ORCID: https://orcid.org/0000-0003-4925-5162)
- Qingmei Li (ORCID: https://orcid.org/0000-0003-2290-1080)
- Qianbing Yin
- Minghua Su (ORCID: https://orcid.org/0009-0003-5552-7977)
- Tumei Su
Institutions
- Guangxi Medical University (CN)
- First Affiliated Hospital of GuangXi Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-04-03
- DOI
- https://doi.org/10.3389/fonc.2025.1574317
- Citations
- 3
- Primary Topic
- Pancreatitis Pathology and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 6.02